🇺🇸 FDA
Pipeline program

DIABECELL(R)

LCT/DIA-06

Phase 2 other completed

Quick answer

DIABECELL(R) for Type 1 Diabetes is a Phase 2 program (other) at Otsuka Beijing Research Institute with 1 ClinicalTrials.gov record(s).

Program details

Company
Otsuka Beijing Research Institute
Indication
Type 1 Diabetes
Phase
Phase 2
Modality
other
Status
completed

Clinical trials